Calithera Biosciences, Inc. (CALA) Is At $6.03 Formed Wedge; M (MTSI)’s Sentiment Is 0.94

MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) Logo

M (MTSI) investors sentiment decreased to 0.94 in Q4 2017. It’s down -0.14, from 1.08 in 2017Q3. The ratio turned negative, as 79 funds increased or started new stock positions, while 84 trimmed and sold stock positions in M. The funds in our database now possess: 57.67 million shares, up from 55.67 million shares in 2017Q3. Also, the number of funds holding M in top ten stock positions increased from 2 to 3 for an increase of 1. Sold All: 41 Reduced: 43 Increased: 56 New Position: 23.

Calithera Biosciences, Inc. (CALA) formed wedge down with $5.60 target or 7.00% below today’s $6.03 share price. Calithera Biosciences, Inc. (CALA) has $215.96M valuation. The stock decreased 1.23% or $0.075 during the last trading session, reaching $6.025. About 86,579 shares traded. Calithera Biosciences, Inc. (NASDAQ:CALA) has declined 36.62% since April 23, 2017 and is downtrending. It has underperformed by 48.17% the S&P500.

Analysts await Calithera Biosciences, Inc. (NASDAQ:CALA) to report earnings on May, 8. They expect $-0.29 EPS, down 31.82% or $0.07 from last year’s $-0.22 per share. After $-0.31 actual EPS reported by Calithera Biosciences, Inc. for the previous quarter, Wall Street now forecasts -6.45% EPS growth.

Investors sentiment increased to 2.2 in 2017 Q4. Its up 0.98, from 1.22 in 2017Q3. It increased, as 10 investors sold Calithera Biosciences, Inc. shares while 20 reduced holdings. 31 funds opened positions while 35 raised stakes. 24.18 million shares or 4.20% less from 25.24 million shares in 2017Q3 were reported. Franklin Resources Inc, a California-based fund reported 715,500 shares. Susquehanna International Group Llp holds 0% of its portfolio in Calithera Biosciences, Inc. (NASDAQ:CALA) for 144,272 shares. Stratos Wealth Prns Limited holds 0% or 690 shares. Rhumbline Advisers reported 0% in Calithera Biosciences, Inc. (NASDAQ:CALA). State Board Of Administration Of Florida Retirement System owns 15,177 shares or 0% of their US portfolio. Ubs Asset Americas invested in 11,000 shares or 0% of the stock. Aqr Ltd has 738,043 shares for 0.01% of their portfolio. Jacobs Levy Equity holds 0% of its portfolio in Calithera Biosciences, Inc. (NASDAQ:CALA) for 18,565 shares. Northern Tru Corporation invested in 338,122 shares or 0% of the stock. Wells Fargo & Co Mn reported 0% of its portfolio in Calithera Biosciences, Inc. (NASDAQ:CALA). Geode Capital Mgmt Limited holds 276,354 shares or 0% of its portfolio. 6,492 were reported by Group One Trading Lp. Strs Ohio reported 3,600 shares. Gam Ag reported 40,200 shares. Renaissance Tech Limited Company reported 0% stake.

Among 5 analysts covering Calithera Biosciences (NASDAQ:CALA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Calithera Biosciences has $1900 highest and $9 lowest target. $14.50’s average target is 140.66% above currents $6.025 stock price. Calithera Biosciences had 10 analyst reports since July 24, 2015 according to SRatingsIntel. Citigroup initiated the stock with “Sell” rating in Tuesday, October 25 report. The stock of Calithera Biosciences, Inc. (NASDAQ:CALA) earned “Buy” rating by H.C. Wainwright on Tuesday, March 28. The firm earned “Buy” rating on Friday, July 24 by Citigroup. The stock of Calithera Biosciences, Inc. (NASDAQ:CALA) earned “Neutral” rating by Citigroup on Tuesday, January 24. Citigroup upgraded the shares of CALA in report on Friday, February 16 to “Buy” rating. The stock has “Market Outperform” rating by JMP Securities on Wednesday, March 9. H.C. Wainwright maintained it with “Buy” rating and $1900 target in Monday, June 12 report. H.C. Wainwright initiated the stock with “Buy” rating in Thursday, January 5 report.

MACOM Technology Solutions Holdings, Inc., together with its subsidiaries, creates and makes analog RF, microwave, millimeter wave, and photonic semiconductor solutions in the United States, the Asia Pacific, and internationally. The company has market cap of $1.09 billion. The firm offers a portfolio of standard and custom devices, which include integrated circuits, multi-chip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems for approximately 40 product lines. It currently has negative earnings. The Company’s semiconductor products are electronic components that are incorporated in electronic systems, such as point-to-point wireless backhaul radios, high density networks, active antenna arrays, radars, magnetic resonance imaging systems, and unmanned aerial vehicles.

Ratings analysis reveals 67% of M A-COM Tech’s analysts are positive. Out of 3 Wall Street analysts rating M A-COM Tech, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $52.0 while the high is $54.0. The stock’s average target of $53 is 213.05% above today’s ($16.93) share price. MTSI was included in 3 notes of analysts from September 20, 2016. Stifel Nicolaus maintained MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) on Wednesday, November 16 with “Buy” rating. Needham maintained MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) rating on Wednesday, February 1. Needham has “Buy” rating and $54.0 target. Goldman Sachs downgraded the shares of MTSI in report on Tuesday, September 20 to “Neutral” rating.

Analysts await MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) to report earnings on May, 1 after the close. They expect $-0.02 EPS, down 104.44% or $0.47 from last year’s $0.45 per share. After $-0.27 actual EPS reported by MACOM Technology Solutions Holdings, Inc. for the previous quarter, Wall Street now forecasts -92.59% EPS growth.

The stock decreased 0.59% or $0.1 during the last trading session, reaching $16.93. About 117,158 shares traded. MACOM Technology Solutions Holdings, Inc. (MTSI) has declined 63.40% since April 23, 2017 and is downtrending. It has underperformed by 74.95% the S&P500.

Colrain Capital Llc holds 3.43% of its portfolio in MACOM Technology Solutions Holdings, Inc. for 127,650 shares. Quentec Asset Management Llc owns 645,962 shares or 3.31% of their US portfolio. Moreover, Litespeed Management L.L.C. has 1.57% invested in the company for 50,000 shares. The Minnesota-based Summit Creek Advisors Llc has invested 1.24% in the stock. Aureus Asset Management Llc, a Massachusetts-based fund reported 187,622 shares.

Calithera Biosciences, Inc. (NASDAQ:CALA) Institutional Positions Chart